Restricted Research - Award List, Note/Discussion Page

Fiscal Year: 2018

1715  University of Houston  (75533)

Principal Investigator: Ming Hu

Total Amount of Contract, Award, or Gift (Annual before 2011): $ 415,455

Exceeds $250,000 (Is it flagged?): Yes

Start and End Dates: 9/1/16 - 11/30/21

Restricted Research: YES

Academic Discipline: PHARMACOLOGICAL & PHARMACEUTIC

Department, Center, School, or Institute: DEAN, PHARMACY

Title of Contract, Award, or Gift: Inhibition of Oral Tumorigenesis by Antitumor B

Name of Granting or Contracting Agency/Entity: National Cancer Institute
CFDA Link: HHS
93.393

Program Title: none
CFDA Linked: Cancer Cause and Prevention Research

Note:

1.1.1 - Our long-term goal is to determine the chemopreventive efficacy of antitumor B (ATB) on oral squamous cell carcinoma and to elucidate the mechanisms of action of ATB.

Discussion: No discussion notes

 

Close Window